FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1996-1998 December 26, 1996 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Geldmacher, D. S. Related Article by Geldmacher, D. S.

To the Editor: In their review of the evaluation of dementia (Aug. 1 issue),¹ Geldmacher and Whitehouse expressed their "opinion . . . that apolipoprotein E testing will not be ready for clinical use as either a predictive or a diagnostic test until better population-based estimates of risk and appropriate genetic counseling are available." There is virtual unanimity regarding the lack of support for apolipoprotein E genotyping in the prediction of asymptomatic persons — whether or not they have relatives with Alzheimer's disease.² No apolipoprotein E genotype predicts accurately whether or when Alzheimer's disease will develop. However, the rationale for . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.